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Standard samples of pure (+)-salutaridine and (-)-thebaine required to study the mammalian origin of 
morphine, were prepared from (+)-6-demethylsalutaridine by published procedures and were characterized 
by CD spectra and physical data. Reductive N-methylation of (-)-northebaine afforded (-)-thebaine, and 
when i3C-labeled formalin was used, (-)-thebaine with a 13C label on the N-methyl carbon atom resulted. 
The latter represents a model procedure to prepare ultimately N-%H,-labeled (-)-thebaine and ‘Y-la- 
beled congeners. 
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1. INTRODUCTION 
( + )-Salutaridine (2) and ( - )-thebaine (5) are in- 
termediates in the biosynthesis of opioids in the 
poppy Papaver somniferum [l]. After iv. injec- 
tion of 2 and 5 in rats, enhanced levels of codeine 
and morphine were detected, suggesting a similari- 
ty in enzymatic degradation of 2 and 5 in both 
plants and mammals [2]. An unambiguous 
preparation and purification of both ( +)- 
salutaridine and (- )-thebaine were necessary to 
rule out contamination and consequently question 
the endogenous origin of the opioids. Using 
established procedures, natural ( - )-thebaine was 
converted into 2 through six intermediates, each of 
which was isolated and purified by recrystalliza- 
* To whom reprint requests should be addressed 
tion, and in some cases by chromatography. The 
nominal absence of codeine and morphine by TLC 
in the thebaine used as starting material, and the 
isolation and purification of six intermediates to 
salutaridine, argue strongly for the absence of co- 
deine and morphine in the salutaridine obtained 
from this sequence. Salutaridine (2) was subse- 
quently reduced to the alcohols 3 and 4 with 
sodium borohydride. Ring closure of unnatural 
( - )-salutaridinol II (4) afforded pure 5 in high 
yield. An alternative pathway to 5 employed reduc- 
tive N-methylation of (- )-northebaine (6); this 
method was also utilized with “C-labeled formalin 
to give N-i3CH3-thebaine (7). This procedure 
represents a useful model reaction for the prepara- 
tion of 14C-labeled thebaine, and 14C-labeled con- 
geners derived from it required to quantitate 
products obtained in the mammalian biosynthesis 
of morphine. 
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2. MATERIALS AND METHODS 
2.1. Synthesis 
Aluminum oxide used for chromatographic 
separations was neutral activated Brockmann I 
grade (Alox) from Aldrich, Milwaukee, WI, Silica 
gel plates used for TLC were from Analtech, 
Newark, DE. The solvent system used for TLC 
analysis was CHCl&ZHsOH/NH40H (90 : 10 : 1) 
and materials were visualized by exposure to iodine 
vapors. (- )-Northebaine (6) was prepared from 
natural ( - )-thebaine by the method of Schwab [3]. 
The following procedures used for converting 5 in- 
to 2, and 2 back into 5, gave the most satisfactory 
results: diphenol 1 was obtained from 5 [4] by a 
route developed by Fleischhacker et al. [S], which 
was found to be simpler and more reliable than the 
bisulfite-mediated oxidation used by Bjeldanes and 
Rapoport [6], Conversion of 1 into 2 was ac- 
complished by protection of the phenolic groups, 
selective deprotection and O-methylation with 
diazomethane, as described by Horvath and 
Makleit [7]. 
( + )-Salutaridine (2) was characterized by its CD 
spectrum shown below. Conversion of 2 into 5 
followed methods used by Barton et al. [8,9]. In 
accord with their findings, reduction of 2 with 
sodium borohydride in methanol afforded 
alcohols 3 and 4, separated by chromatography on 
Alox. The slower moving unnatural alcohol 4 was 
cyclized to 5 with DMF-dineopentylacetal, as 
described by White et al. [lo]. CD spectra of 
natural ( - )-salutaridinol I (3), ( - )-thebaine (5) 
and ( - )-codeine are also recorded here. Thebaine 
prepared from 2 was found to be identical with the 
natural alkaloid after purification on Alox and 
crystallization from ethanol. Both samples gave 
identical physical data, and essentially identical to 
those reported [4]. 
Reductive N-methylation of 6 with formalin and 
sodium cyanoborohydride in acetonitrile [ 1 l] and 
purification of 5 as the tartrate salt afforded 5 
after usual transformation into the base in very 
good yield. Repetition of the experiment with 13C- 
labeled formalin [12] gave ( - )-thebaine (7), with a 
13C label on the N-methyl carbon atom. The 
physical properties of 7 were almost identical to 
those found for 5, however, the ‘HI-NMR spectrum 
of 7 showed the expected doublet (1J13~~ = 
133 Hz) centered at 6 2.38 for the N-13CH3 group. 
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The spectrum also showed 5% N-12CH3-thebaine 
as revealed by a singlet at 6 2.38 due to isotopic im- 
purity in the [13C]formalin employed for reductive 
alkylation. The chemical ionization MS of 7 
showed the expected molecular ion at 3 13 (M + l), 
one mass unit higher than 312 (M + 1) observed for 
5, 
2.2. CD spectral determination 
The CD spectra were recorded in ethanol at 
room temperature on a Jasco model J-500A re- 
cording spectropolarimeter, equipped with a Jasco 
model DP-SOON data processor, and an OK1 
IF-800 model 30 microcomputer. 
The CD spectra are in agreement (within ex- 
perimental error) with those reported in the 
literature [ 131. The spectral patterns are 
characteristic for each of these compounds and 
reveal more fine structure than reported [13]. Our 
CD spectrum of thebaine exhibits a true Cotton ef- 
fect at 242/3 nm whereas a shoulder is shown in 
the literature in the same wavelength area (due to 
the latest refinement of instrumental techniques 
such as data averaging, use of microcomputers, 
etc. one can detect more details). 
As mentioned by Crabbe [14], the intensity of 
the Cotton effects of these compounds is quite 
high, especially below 250 nm, presumably due to 
the electric dipole-electric dipole or magnetic 
dipole-electric dipole coupling between the transi- 
tion moments of the aromatic chromophore and 
ethylene, diene or A’p4-3-keto chromophores. 
3. EXPERIMENTAL 
3.1, 6-Demethyisaiutaridine (I) from commercial 
thebaine (5) 
Thebaine (5), free of codeine and morphine by 
TLC, was converted as described [5] in three steps 
to 1 which showed m.p. 185-187°C ((51: m.p. 
184-186°C). 
3.2. (+)-Salutaridine (2) from 6-demethyi- 
saiutaridine (I/ 
Preparation of 2 from 1 was accomplished using 
the four-step sequence of Horvath and Makleit [7] + 
2 showed m.p. 201-202°C; [a]$! + 113” (c 0.45, 
MeOH), [G# +87” (c 0.49, CHCl3) ([7]: m.p. 
197-198°C [a]g + 114” (c 0.5, MeOH)). 
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Fig.1. CD spectra in ethanol: (-) codeine, (---) thebaine (5), (-----) salutaridine (Z), (-----) salutaridinol (3). 
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3.3. Natural (-)-thebaine (5) from 
(+ )-salutaridine (2) 
Salutaridinol (4) II was prepared by NaBH4 
reduction and purified by chromatography as in 
[8,9]. To material (4, 250 mg, 0.76 mmol) in 
chloroform (15 ml) was added DMF- 
dineopentylacetal [lo] (0.65 ml, 2.33 mmol) and 
the suspension was allowed to stir overnight. 
Evaporation in vacua afforded a green residue 
which was chromatographed on Alox II with 
chloroform as an eluant, affording 180 mg the- 
baine (78%). A sample crystallized from ethanol 
had m.p. 196°C ([4]: 193°C) and [cy]$? -220°C (c 
2.0, ethanol) ([4]: [a$ -219” (c 2.0, ethanol)). 
Analysis: calcd for C19HziNO3 (311.37): C 73.29, 
H 6.80, N 4.50%; found: C 73.09, H 6.93, N 
4.53%. 
3.4. (-)-Thebaine (5) from (-)-northebaine (6) 
A modification of the procedure for N- 
methylation of amines, by Borch and Hassid [l l] 
was used. To a solution of 6 (300 mg, 1 mmol) in 
CH&N (3 ml), 37% formaldehyde solution 
(0.24 ml, 3 mmol) was added, followed by 
NaBHrCN (100 mg, 1.6 mmol) at 0°C. The reac- 
tion mixture was allowed to stir at room 
temperature for 30 min and then neutralized to pH 
6-7 by dropwise addition of glacial acetic acid. 
After stirring for 45 min, the volatiles were re- 
moved in vacua and 2 N KOH (4 ml) was added to 
the resulting golden syrup. Extraction with CHCI3 
(3 x 10 ml) followed by washing of the combined 
CHCl3 fractions with 0.5 N KOH (1 x 10 ml) and 
evaporation of solvent in vacua yielded 310 mg 
crude 5 as the free base. Thebaine was dissolved in 
hot MeOH (5 ml) and d-tartaric acid (150 mg, 
1 mmol) in MeOH (1 ml) was added, resulting in 
400 mg (86%) of white tartrate, m.p. 227-229°C. 
Conversion to the free base gave crystalline 5; TLC 
showed a homogeneous spot identical to an 
authentic sample of 5; m.p. 192-193°C ([4]: 
193°C); MS (CI) M+ 1 = 312; [a]:: -216.5” (c 
1.09, CHCl3) ([4]: [@I’d -230” (c 5.0, CHC13)). 
3.5. 13CH3-thebaine (7) 
The method described above was followed, 
substituting 37% formaldehyde with 20% 
i3CH3-formalin [12] (460 mg, 3 mmol). 13CH3- 
thebaine (7) was isolated as the d-tartrate in 84% 
yield of m.p. 227-229’C. Conversion to the free 
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base gave crystalline material; TLC showed the 
material to be homogeneous and identical with 
natural thebaine; m.p. 192-193°C; MS (CI) 
M+ 1 = 313; [cy]? -214.8” (c 1.07, CHC13). 
4. CONCLUSIONS 
Although the amounts of codeine and morphine 
detected in rat tissues after administration of 2 and 
5 are in the femtomolar range, the levels are 
enhanced as compared to control data and thus 
their origin is quite possibly of endogenous nature. 
Quantitation of endogenous opioids resulting from 
administration of precursors of morphine and co- 
deine would undoubtedly be facilitated with the 
availability of 14C-labeled compounds. Although 
N-demethylation of opioids is a possible route of 
metabolism [15], the fact that codeine and mor- 
phine with intact N-methyl groups could be 
detected in rat tissue after application of 2 and 5 
rationalizes the use of 14C-labeled ( - )-thebaine 
with the label in the N-methyl group as a valuable 
compound. The successful N-methylation of (-)- 
northebaine (6) with i3C-labeled formalin, 
therefore, represents a useful model reaction to 
prepare such 14C-labeled probes. 
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